JAK3 and extranodal nasal NK/T cell lymphoma: In natural killer T-cell lymphoma (NKTCL), JAK3 mutations (A572V/A573V) occur in approximately 35% of cases and drive constitutive JAK3/STAT5 activation, promoting proliferation (190).